These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 24856285

  • 1. [Cost of multiple sclerosis in France].
    Fromont A, Lehanneur MN, Rollot F, Weill A, Clerc L, Bonithon Kopp C, Binquet C, Moreau T.
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G, Berg J, Lindgren P, Anten B, Ekman M, Jongen PJ, Polman C, Uitdehaag B.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [Abstract] [Full Text] [Related]

  • 6. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z, Hazan R, Barak Y, Achiron A.
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [Abstract] [Full Text] [Related]

  • 7. Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
    Vandhuick O, Payet M, Préaud E, Lortet-Tieulent J, Raguideau F, Chevreuil O, van Hille B, Kwiatkowski A.
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1135-1144. PubMed ID: 34165377
    [Abstract] [Full Text] [Related]

  • 8. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G, Berg J, Lindgren P, Plesnilla C, Baumhackl U, Berger T, Kolleger H, Vass K.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [Abstract] [Full Text] [Related]

  • 9. Peripheral arterial obliterative disease. Cost of illness in France.
    Montron A, Guignard E, Pelc A, Comte S.
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):51-9. PubMed ID: 10175985
    [Abstract] [Full Text] [Related]

  • 10. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
    Fischer F, Hoffmann K, Mönter N, Walle M, Beneke R, Negenborn S, Weinmann S, Willich SN, Berghöfer A.
    Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
    [Abstract] [Full Text] [Related]

  • 11. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G, Berg J, Lindgren P, Izquierdo G, Sánchez-Soliño O, Pérez-Miranda J, Casado MA, Associación Española de Esclerosis Múltiple.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P, Rivière S, Rigault A, Tala S, Drouin J, Pestel L, Denis P, Gastaldi-Ménager C, Gissot C, Juillière Y, Fagot-Campagna A.
    Arch Cardiovasc Dis; 2016 Sep; 109(6-7):399-411. PubMed ID: 27079468
    [Abstract] [Full Text] [Related]

  • 13. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J, Lindgren P, Fredrikson S, Kobelt G.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [Abstract] [Full Text] [Related]

  • 15. [Direct and indirect costs of fractures due to osteoporosis in Austria].
    Dimai HP, Redlich K, Schneider H, Siebert U, Viernstein H, Mahlich J.
    Gesundheitswesen; 2012 Oct; 74(10):e90-8. PubMed ID: 22422076
    [Abstract] [Full Text] [Related]

  • 16. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G, Berg J, Lindgren P, Gerfin A, Lutz J.
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [Abstract] [Full Text] [Related]

  • 17. Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.
    Bruno D, Marc D, Ouarda P, Dominique S, Marc S, Laurène C, Khalil J, Jonathan E, Francis G.
    Mult Scler Relat Disord; 2019 Nov; 36():101396. PubMed ID: 31525627
    [Abstract] [Full Text] [Related]

  • 18. [Reimbursed health expenditures during the last year of life, in France, in the year 2008].
    Ricci P, Mezzarobba M, Blotière PO, Polton D.
    Rev Epidemiol Sante Publique; 2013 Feb; 61(1):29-36. PubMed ID: 23318018
    [Abstract] [Full Text] [Related]

  • 19. [The cost of treatment of multiple sclerosis in Colombia].
    Romero M, Arango C, Alvis N, Suarez JC, Duque A.
    Value Health; 2011 Feb; 14(5 Suppl 1):S48-50. PubMed ID: 21839899
    [Abstract] [Full Text] [Related]

  • 20. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
    Allegra C.
    Curr Med Res Opin; 2003 Feb; 19(8):761-9. PubMed ID: 14687448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.